Best of ILCA 2020

HomeEducationBest of ILCA 2020

Best of ILCA 2020
Learn the latest in clinical practice and research in liver cancer

Thursday, 25th February 2021
7am EST | 1pm CET | 8pm SGT

As 2021 gets into gear, ILCA’s liver cancer experts present this webinar based on key selected sessions of the ILCA 2020 Annual Conference.

Join ILCA’s first webinar of the year to learn about 2020’s key takeaways on prevention, diagnosis, treatment, and care of liver cancer patients as well as the latest in clinical practice and research in liver cancer.

This event is free to join. Register now to reserve your complimentary seat.

What’s on the Agenda

ILCA – the 2020 conference unwrapped
Join ILCA’s Executive Secretary Augusto Villanuevaaward winner, researcher and author, as he shares his personal highlights from the 2020 ILCA conference. As Augusto breaks down the conference programme, get inspired by some of the best content of the top leaders in liver cancer. Tune in for a session that has something for everyone.

ILCA Guidance on systematic therapies in HCC – the expert guide
Do you want to build your knowledge and competency about systemic therapies in HCC?
Join Stephen Chan, a highly-regarded Hong Kong-based oncologist specialising in HCC being involved on the ILCA’s 2020 guidance on systemic therapies, for his take on this rapidly evolving therapeutic area. Stephen will share the most up-to-date recommendations in this must-see presentation.

Discover new developments in sequencing therapies in HCC
What are the new developments that took hold in the past year? What are the new therapies we all need to get to grips with and what are the most appropriate sequencing pathways for these agents? Join Lorenza Rimassa, prolific peer-reviewed author and Associate Editor for Liver Cancer International, as she reviews the latest developments in sequencing therapies in HCC as presented in the 2020 ILCA conference. Lorenza will highlight those with the strongest results and present her own conclusions.
Three clinical studies you really need to know about
What insights and tips can we learn from the many clinical studies presented at ILCA 2020? Join Joong-Won Park, world-renowned key opinion leader and former head of the Center for Liver Cancer, NCC in Republic of Korea, for his talk about the three clinical studies which impressed him the most. Be inspired by bold, brilliant research that will make you think beyond the bounds of traditional approaches.

What I learnt – embracing the best basic & translational research
Go behind-the-research to learn what inspired translational researcher and Associate Editor of the Journal of Hepatology, Jean-Charles Nault, from all the basic and translational research presentations at ILCA 2020. Get learnings and perspectives from the best presentations as you join Jean-Charles’ captivating “What I learnt” talk.

Moderator:

Best of ILCA 2020

Augusto Villanueva
Assistant Professor in the Liver Cancer Program,
Icahn School of Medicine at Mount Sinai, New York

Expert Panel:

Best of ILCA 2020

Stephen Chan
Associate Professor, Department of Clinical Oncology,
the Chinese University of Hong Kong, Hong Kong

Best of ILCA 2020

Lorenza Rimassa
Associate Professor of Medical Oncology
Director of the Residency Program in Medical Oncology
Department of Biomedical Sciences – Humanitas University
Deputy Director – Medical Oncology Unit – Humanitas Cancer Center
IRCCS Humanitas Research Hospital

Best of ILCA 2020

Joong-Won Park
Professor, Principal Scientist, Center for Liver and Pancreatobiliary Cancer,
National Cancer Center, Korea

Best of ILCA 2020

Jean-Charles Nault
Associate Professor in Liver unit,
Avicenne hospital, Bobigny, France

  • UPCOMING WEBINAR: Primary and acquired resistance to immunotherapy in HCC: from research to practice and viceversa. 11 November 2021.